<?xml version="1.0" encoding="UTF-8"?>
<p>The activity of another compound containing a Î²-amino acid moiety, ketorolac (the brand name Toradol
 <bold>,</bold>
 <xref rid="molecules-26-00438-t003" ref-type="table">Table 3</xref>, Compound 
 <bold>14</bold>), is related to blocking cyclooxygenase 1 and 2 (COX-1 and COX-2), thereby decreasing the production of prostaglandins. Contraindications to ketorolac are the risk of gastrointestinal bleeding, risk of renal failure, compromised hemostasis, hypersensitivity to aspirin or other NSAIDs, labor, delivery, and nursing [
 <xref rid="B42-molecules-26-00438" ref-type="bibr">42</xref>].
</p>
